These findings were further validated by results showing that miR‐383 levels were twofold higher in AML1‐ETO+ than AML1‐ETO− AML blasts (Fig 4F) in an additional cohort of 124 AML cases (Appendix Table S5). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.